Inflammatory cytokines in vascular dysfunction and vascular disease

Area of Science:

• Vascular biology and immunology
• Cellular and molecular mechanisms of inflammation

Background:

• Vascular inflammation involves intricate interactions between immune cells, endothelial cells (ECs), vascular smooth muscle cells (VSMCs), and the extracellular matrix (ECM).
• Vascular injury triggers the release of adhesion molecules, inflammatory cells, growth factors, and cytokines, influencing ECs, VSMCs, and ECM composition.
• Cytokines, produced by various cells, bind to receptors and activate key signaling pathways (JAK-STAT, NF-kappaB, Smad), mediating cellular responses.

Purpose of the Study:

• To elucidate the multifaceted role of cytokines in the vascular inflammatory response.
• To explore how cytokine signaling affects endothelial and smooth muscle cell function.
• To identify potential therapeutic targets for inflammatory vascular diseases.

Main Methods:

• Review of existing literature on vascular inflammation and cytokine signaling pathways.
• Analysis of cytokine interactions with cellular receptors and intracellular signaling cascades.
• Examination of cytokine effects on vasodilatory/vasoconstrictive mediators and cell proliferation.

Main Results:

• Cytokines activate JAK-STAT, NF-kappaB, and Smad pathways, increasing reactive oxygen species and influencing cell adhesion, permeability, and apoptosis.
• Cytokine-induced EC activation alters the balance of vasodilators (e.g., nitric oxide) and vasoconstrictors (e.g., endothelin).
• Cytokines promote VSMC growth, migration, and reactivity via Ca(2+), PKC, Rho-kinase, and MAPK pathways, and modify ECM through integrins and MMPs.

Conclusions:

• Persistent cytokine elevation contributes to vascular dysfunction and diseases including atherosclerosis, aneurysms, varicose veins, and hypertension.
• Strategies to reduce cytokine production or block their effects with antagonists represent promising therapeutic avenues for inflammatory vascular conditions.